Financhill
Back

Algernon Pharmaceuticals Quote, Financials, Valuation and Earnings

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade
Buy
61

AGN.CX
Algernon Pharmaceuticals

Last Price:
0.09
Seasonality Move:
42.23%

7 Day Trial

ALL ACCESS PASS

$ 7

U.S. Government Report Alert Tuesday

Discover the Secret Loophole

Algernon Pharmaceuticals Price Quote

$0.09
+0.00 (+5.88%)
(Updated: November 6, 2024 at 2:22 AM ET)

Algernon Pharmaceuticals Key Stats

Buy
61
Algernon Pharmaceuticals (AGN.CX) is a Buy

Day range:
$0.08 - $0.09
52-week range:
$0.05 - $0.17
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%

Volume:
8.4K
Avg. volume:
18.2K
1-year change:
13.33%
Market cap:
$820.6K
Revenue:
$0
EPS:
$-0.89

How Much Does Algernon Pharmaceuticals Make?

Data Unavailable

Is Algernon Pharmaceuticals Growing As A Company?

Data Unavailable

Algernon Pharmaceuticals Stock Price Performance

What Is Algernon Pharmaceuticals 52-Week High & Low?

Algernon Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Algernon Pharmaceuticals?

Is Algernon Pharmaceuticals Cash Flow Positive?

  • What Is AGN.CX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$4.1M
  • What Is Algernon Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $2.2M
  • What Is Algernon Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$122.3K

Algernon Pharmaceuticals Return On Invested Capital

Data Unavailable

Algernon Pharmaceuticals Earnings Date & Stock Price

Algernon Pharmaceuticals Competitors

Algernon Pharmaceuticals Dividend Yield

Algernon Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -13.04%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 2.56
Upside from Last Price: 2914.71%

Major Shareholders

  • How many AGN.CX shares are owned by institutional investors?
    100 AGN.CX shares are owned by institutional investors
  • How many AGN.CX shares are owned by insiders?
    0 AGN.CX shares are owned by insiders